U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938204) titled 'Single Ascending Dose, Multiple Ascending Dose, Food Effect Study' on April 03.
Brief Summary: This is a 2-part study. Parts 1 and 2 will be a randomized, double-blind, placebo-controlled investigations of SAD (Part 1) and MAD (Part 2) of orally administered INV-101 in healthy adult subjects. Food effect will also be assessed in one cohort in Part 1.
Study Start Date: April 01, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: INV-101
SAD MAD
DRUG: INV-101 Placebo
SAD MAD
Recruitment Status: COMPLETED
Sponsor: Innovo Therapeutics, Inc.
Published by HT Digital Content Services with permissi...